Skip to main content

Illumina, Solexa Shareholders to Vote on Acquisition Details Jan. 26

NEW YORK (GenomeWeb News) — Illumina and Solexa shareholders will meet independently on Jan. 26, 2007 to vote on aspects of Illumina’s $600 million bid to acquire Solexa, Illumina said today.
 
Solexa shareholders will meet to consider and vote on the deal, while Illumina stockholders will meet to consider issuing Illumina shares to Solexa stockholders.
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.